(Date:11/19/2009)..., VIENNA, Austria, November 19 ...gram on one product candidate at an unexpectedly e...D02 is planned to enter into,Phase II clinical tri...ediately follows the completion of two Phase I tri... based its fast decision on the first interim,anal...
(Date:11/18/2009)...t the National Institute of Standards and Technolo...expensive method for detecting and measuring elusi..., invisible spoilage in food or pesticides distrib...d is more sensitive than conventional techniques f...polarlike water molecules, having distinct electri...
(Date:11/18/2009)..., Ill. Imagine a polka-dotted postage stamp that ...ply by changing colors. , As reported in the Sep...neth Suslick and his team at the University of Ill...neral detection of toxic industrial chemicals (TIC... by visualizing odors. This sensor array could be...
(Date:11/18/2009)...ICHMOND, Calif., Nov. 18 ...ced today that data from the University of Pennsyl...of Sangamo,s zinc finger nuclease (ZFN) based prod... prematurely disclosed on the internet. ,, Data...ity of Pennsylvania School of Medicine from a sing...
Breaking Biology Technology:AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3Prototype NIST method detects and measures elusive hazards 2Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2.... (Nasdaq: HGSI ) announced today that its presen...erence will be webcast and may be accessed,at htt.../cgi-bin/prnh/20010612/HGSLOGO ), A member of Hu...resent,an overview of the company on Wednesday, Ja... Eastern Time., Investors interested in listening...
...reatment of multi-drug res...b-X Pharmaceuticals, Inc.,("Rib-X" or the "Company...elopment of novel antibiotics for the treatment of...the enrolment of the first patients in two,separat...te the safety and,efficacy of RX-1741 in the treat...
... THRM ), a leader in non-invasive tissue tightenin...it will present at the 10th Annual Needham &,Compa...rk City. The,Company,s presentation is scheduled f...Time. Stephen J. Fanning, Chairman, President and ... business strategy and,historical financial result...
Other Biology Technology:Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741 2Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741 3... to indicate that the diversity of marine creature...s of years in step with predator-prey encounters, ...ngs of the National Academy of Science. , For dec...sts, biologists, and ecologists on the role of eco...ng term patterns of animal evolution. , John War...
...tant to UNESCO and a former Administrator of the N...AA), will deliver a talk at Stevens Institute of T...e Habitability of Planet Earth: A Time of Reckonin... Center for Technology Management, Room 122, at 3:... the Stevens campus in Hoboken, N.J., near the int...
...harmaceuticals (NASDAQ: ABPI) announces evidence t...S), are due to a fungal-induced inflammation as or...nic. The data were collected as part of the Compa... lead pharmaceutical product, SinuNase, an intrana....01% suspension. In order to be enrolled in the c...
Other Biology News:Study reveals predation-evolution link 2Study reveals predation-evolution link 3Global Warming and the Habitability of Planet Earth, Sept. 26 2SinuNase Phase 3 show almost 100 percent of chronic sinusitis cases are from fungal-induced inflamma 2Rabbit anti-QKI AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories
Direct ELISA Assay Diluent from BioFX Laboratories, Inc.
Assay Diluent from BioFX Laboratories, Inc.
Assay Diluent Trial Pack from BioFX Laboratories, Inc.
Biology Products: